# Filing Detail

Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
SEC Accession No. 0001193125-26-261719
Filing Date
2026-06-08
Accepted
2026-06-08 16:08:22
Documents
10

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFM14A | d76493ddefm14a.htm | DEFM14A | 1629653
2 | GRAPHIC | g76493g01a01.jpg | GRAPHIC | 35766
3 | GRAPHIC | g76493g01a02.jpg | GRAPHIC | 36182
4 | GRAPHIC | g76493g02a02.jpg | GRAPHIC | 51870
5 | GRAPHIC | g76493g03a03.jpg | GRAPHIC | 33981
6 | GRAPHIC | g76493g04a04.jpg | GRAPHIC | 53287
7 | GRAPHIC | g76493g05a05.jpg | GRAPHIC | 33997
8 | GRAPHIC | g76493g07a07.jpg | GRAPHIC | 53366
9 | GRAPHIC | g76493g54i83.jpg | GRAPHIC | 200824
10 | GRAPHIC | g76493g74w69.jpg | GRAPHIC | 241624
| Complete submission text file | 0001193125-26-261719.txt |  | 2600449

Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFM14A | Act: 34 | File No.: 001-33057 | Film No.: 261072670
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)